4,141 trials (keyword fallback)
Hypertension, Pregnancy-Induced · Postpartum Preeclampsia · Hypertension; Maternal
Primary: Proportion of Participants With Recorded Blood Pressure Values in Office — 43; 44; 49; 56 Participants
Uterine Atony With Hemorrhage
Primary: Number of Participants With Need for Additional Uterotonics (Methylergonovine, Carboprost, Misoprostol) — 80; 80 Participants
Obstetric Labor Complications · Hemorrhage · Complications; Cesarean Section
Primary: Fibrinogen Level at 2 Hours After Delivery — 186; 418 mg/dL — p=<0.05
Complications; Contraceptive · Female Lactation
Primary: Time to Lactogenesis Stage II — 64.3; 65.2 hours — p=<0.05
Postpartum
Primary: Number of Participants With Implant Use at Three Months — 28; 2 Participants
Contraception
Primary: IUD Expulsion Rate — 20; 7 Participants
Maternal Behavior · Postpartum Depression
Primary: Emergency Department (ED) Visits and Readmissions — 18; 21 Postpartum Hospital Use
Contraception · Malposition of Intrauterine Contraceptive Device
Primary: Number of Participants Who Would Recommend the LNG-IUS to a Friend at 6-months Postpartum. — 40 Participants
Pregnancy Related · Postpartum Sadness
Primary: Change From Baseline Resilience at 4 Weeks — 26.57; 28.29; 1.85 score on a scale — p=<.001
Pain, Postoperative
Primary: Postoperative Pain on a Visual Analogue Pain Scale at One Hour Postoperatively — 4.04; 5.09; 4.4 units on a scale
Perineal Injury
Primary: Severity of Postpartum Perineal Pain — 8.200; 8.280; 4.500; 8.080 score on a scale
Chronic Pain
Primary: Medical Record Review and Treatment Utilization Form — 19; 17 Participants — p=.6469
Continuation Rate of Contraceptive Implant
Primary: Continuation Rate — 20; 18 participants
Maternal Death · Maternal Morbidity
Primary: Number of Participants Attending a Comprehensive Postpartum Visit — 84; 89 Participants
Hypertensive Disorder of Pregnancy · Pre-Eclampsia · Hypertension
Primary: Percent of Participants Eligible, Enrolled and Retained (Feasibility) — 61 Participants